Generalized pustular psoriasis treated with ustekinumab

Clin Exp Dermatol. 2016 Aug;41(6):689-90. doi: 10.1111/ced.12868. Epub 2016 Jun 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acitretin / administration & dosage
  • Acitretin / adverse effects
  • Acitretin / therapeutic use
  • Adalimumab / administration & dosage
  • Adalimumab / adverse effects
  • Adalimumab / therapeutic use
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Cyclosporine / administration & dosage
  • Cyclosporine / therapeutic use
  • Drug Resistance / physiology
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Keratolytic Agents / therapeutic use
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • Skin Diseases, Vesiculobullous / drug therapy*
  • Skin Diseases, Vesiculobullous / pathology
  • Treatment Outcome
  • Ustekinumab / administration & dosage
  • Ustekinumab / therapeutic use*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Keratolytic Agents
  • Cyclosporine
  • Ustekinumab
  • Adalimumab
  • Acitretin
  • Methotrexate